About this trial
This research is for patients who have gastrointestinal cancer and have a planned major surgery. The purpose of this research is to identify cancer patients who may be at risk for frailty. Frailty is common in older adults and may include symptoms of weight loss, weakness, fatigue, low activity, slow walking and other illnesses. Frailty may increase the risk of problems after major surgery. The study will involve a survey, a blood sample, and a review of medical records.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
18 years old or older
histologically proven gastrointestinal malignancy
referral for elective major surgical procedures at including operations for upper and lower gastrointestinal malignancies and hepato-pancreato-biliary
referral for neoadjuvant treatment followed by any of the above major surgical procedures
Disqualifiers
under 18 years
pregnant women
Trial population
Participants with gastrointestinal cancer who are referred for elective major surgery
Trial design
Cohort
Prospective
Treatments tested in this trial
Frailty survey
Other interventionFrailty survey using the Clinical Risk Analysis Index (RAI-C).
Treatment groups
Trial outcomes
Primary outcomes
Percent of patients considered frail assessed by Clinical Risk Analysis Index (RAI-C) Scores of 21 or higher
Assess Clinical Risk Analysis Index (RAI-C) Scores in rural patients referred for major abdominal surgeries. Survey values will be added to yield a final RAI-C score between 0 and 81. Percent of patients considered frail will be defined as Clinical Risk Analysis Index (RAI-C) Scores of 21 or higher
Secondary outcomes
Adverse outcomes after major surgery
Assess adverse outcomes postoperatively and if their is a correlation with the frailty score
Sponsors and contacts
Click on the lead sponsor to view all of their trials.